{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:24:44Z","timestamp":1772166284237,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-025-02598-8","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:54:46Z","timestamp":1740124486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Stereotactic body radiotherapy (SBRT) as a treatment for localized prostate cancer: a retrospective analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Brecht","family":"De Cooman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibaut","family":"Debacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Lamberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"De Troyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Claessens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"De Kerf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet","family":"Dirix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet","family":"Ost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"issue":"10","key":"2598_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.811044","volume":"16","author":"L Wang","year":"2022","unstructured":"Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health. 2022;16(10): 811044.","journal-title":"Front Public Health"},{"issue":"6","key":"2598_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877\u201392.","journal-title":"Eur Urol Oncol"},{"issue":"17","key":"2598_CR3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","volume":"388","author":"FC Hamdy","year":"2023","unstructured":"Hamdy FC, Donovan JL, Lane JA, Metcalfe C, Davis M, Turner EL, et al. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2023;388(17):1547\u201358.","journal-title":"N Engl J Med"},{"issue":"11","key":"2598_CR4","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","volume":"20","author":"DH Brand","year":"2019","unstructured":"Brand DH, Tree AC, Ostler P, Van Der Voet H, Loblaw A, Chu W, et al. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol. 2019;20(11):1531\u201343.","journal-title":"Lancet Oncol"},{"issue":"4","key":"2598_CR5","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.3390\/curroncol28040257","volume":"28","author":"MA G\u00f3mez-Aparicio","year":"2021","unstructured":"G\u00f3mez-Aparicio MA, Valero J, Caballero B, Garc\u00eda R, Hernando-Requejo O, Montero \u00c1, et al. Extreme hypofractionation with SBRT in localized prostate cancer. Curr Oncol. 2021;28(4):2933\u201349.","journal-title":"Curr Oncol"},{"key":"2598_CR6","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Paris April 2024. ISBN 978\u201394\u201392671\u201323\u20133."},{"key":"2598_CR7","volume":"47","author":"N Sundahl","year":"2024","unstructured":"Sundahl N, Brand D, Parker C, Dearnaley D, Tree A, Pathmanathan A, et al. Weekly ultra-hypofractionated radiotherapy in localised prostate cancer. Clin Trans Radiat Oncol. 2024;47: 100800.","journal-title":"Clin Trans Radiat Oncol"},{"key":"2598_CR8","doi-asserted-by":"crossref","unstructured":"Van As N, Yasar B, Griffin C, Patel J, Tree AC, Ostler P, et al. Radical prostatectomy versus stereotactic radiotherapy for clinically localised prostate cancer: results of the pace-a randomised trial. European Urology. 2024 Sep; S0302283824025685","DOI":"10.1016\/j.eururo.2024.08.030"},{"issue":"4","key":"2598_CR9","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","volume":"104","author":"WC Jackson","year":"2019","unstructured":"Jackson WC, Silva J, Hartman HE, Dess RT, Kishan AU, Beeler WH, et al. Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6000 patients treated on prospective studies. Int J Radiat Oncol Biol Phys. 2019;104(4):778\u201389.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"2598_CR10","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","volume":"391","author":"N Van As","year":"2024","unstructured":"Van As N, Griffin C, Tree A, Patel J, Ostler P, Van Der Voet H, et al. Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer. N Engl J Med. 2024;391(15):1413\u201325.","journal-title":"N Engl J Med"},{"issue":"1","key":"2598_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1748-717X-8-118","volume":"8","author":"AJ Katz","year":"2013","unstructured":"Katz AJ, Santoro M, Diblasio F, Ashley R. Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years. Radiat Oncol. 2013;8(1):118.","journal-title":"Radiat Oncol"},{"issue":"2","key":"2598_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.radonc.2013.08.030","volume":"109","author":"CR King","year":"2013","unstructured":"King CR, Freeman D, Kaplan I, Fuller D, Bolzicco G, Collins S, et al. Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol. 2013;109(2):217\u201321.","journal-title":"Radiother Oncol"},{"issue":"2","key":"2598_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S1470-2045(21)00705-1","volume":"23","author":"AU Kishan","year":"2022","unstructured":"Kishan AU, Sun Y, Hartman H, Pisansky TM, Bolla M, Neven A, et al. Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis. Lancet Oncol. 2022;23(2):304\u201316.","journal-title":"Lancet Oncol"},{"issue":"3","key":"2598_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.eururo.2016.02.057","volume":"70","author":"P Dell\u2019Oglio","year":"2016","unstructured":"Dell\u2019Oglio P, Abou-Haidar H, Leyh-Bannurah SR, Tian Z, Larcher A, Gandaglia G, et al. Assessment of the rate of adherence to international guidelines for androgen deprivation therapy with external-beam radiation therapy: a population-based study. Eur Urol. 2016;70(3):429\u201335.","journal-title":"Eur Urol"},{"issue":"1","key":"2598_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/21681805.2019.1702093","volume":"54","author":"G George","year":"2020","unstructured":"George G, Garmo H, Rudman S, Holmberg L, Robinson D, Stattin P, et al. Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden. Scandinavian J Urol. 2020;54(1):20\u20136.","journal-title":"Scandinavian J Urol."},{"issue":"10323","key":"2598_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0140-6736(21)02437-5","volume":"399","author":"G Attard","year":"2022","unstructured":"Attard G, Murphy L, Clarke NW, Cross W, Jones RJ, Parker CC, et al. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Lancet. 2022;399(10323):447\u201360.","journal-title":"Lancet"},{"issue":"11","key":"2598_CR17","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1200\/JCO.20.03282","volume":"39","author":"V Murthy","year":"2021","unstructured":"Murthy V, Maitre P, Kannan S, Panigrahi G, Krishnatry R, Bakshi G, et al. Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase iii randomized controlled trial. JCO. 2021;39(11):1234\u201342.","journal-title":"JCO"},{"issue":"2","key":"2598_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034623","volume":"10","author":"V Murthy","year":"2020","unstructured":"Murthy V, Mallick I, Gavarraju A, Sinha S, Krishnatry R, Telkhade T, et al. Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL). BMJ Open. 2020;10(2): e034623.","journal-title":"BMJ Open"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02598-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02598-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02598-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:54:50Z","timestamp":1740124490000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-025-02598-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2598"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02598-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5298640\/v1","asserted-by":"object"}]},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"20 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of the ZAS Augustinus Hospital in Antwerp approved this study in August 2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}